Nucynta: payments to doctors
Payments that named Nucynta as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2.3M
- Providers
- 1,044
- Transactions
- 3,000
- Average per transaction
- $783
The per-transaction average — $783 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,044 providers the average total is $2,249, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Collegium Pharmaceutical, Inc. | $2,346,745 | 99.9% |
| Assertio Therapeutics, Inc. | $1,625 | 0.1% |